An “anaerobic invisible” genetically engineered bacterium for periodontitis treatment through temporal modulation on microenvironment
Dental Research · 2026-01 · 1 (1) · 100002
DOI: 10.1016/j.dtrs.2025.100002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dental Research, 2026-01. Verfasst von Jiwei Sun und 14 weiteren Autor:innen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Periodontitis is a highly prevalent chronic inflammatory disease, primarily driven by microbial dysbiosis and subsequent dysregulation of host immune responses. Therefore, targeting the pathogenesis, modulating the balance of periodontal microbiota, and subsequently controlling local inflammatory responses may offer an effective therapeutic strategy for periodontitis. Here, we propose a "bacteria-versus-bacteria" temporal therapeutic strategy and developed a genetically engineered strain HbEcN-PEI-MTZ@MnO 2 (HEpM) for periodontitis. This two-stage temporal therapy begins with pH-responsive release of metronidazole (MTZ) anchored on HEpM, eliminating periodontal pathogens and rebalancing the microbial dysbiosis. Concurrently, the engineered HEpM was endowed with a local oxygen supply system via the expression of Vitreoscilla hemoglobin (VHb), which enables HEpM to release oxygen as an oxygen-protective barrier forming a protective "anaerobic invisible cloak" that safeguards HEpM from the self-inflicted cytotoxicity of metronidazole. In the second therapeutic phase, remote thermal activation triggers the expression of anti-inflammatory enzymes to mitigate oxidative stress induced by microbial dysbiosis. Consequently, HEpM temporal therapy effectively reshaped the oral microbial community, reducing periodontal pathogens and biofilm formation. Single-cell RNA sequencing analysis further revealed a reduction in inflammatory CXCL1 + fibroblasts and enhanced fibroblast-centered intercellular communication, which facilitated immune microenvironment remodeling. This study establishes a smart, bacteria-based platform for temporal and targeted therapy of periodontitis, offering a novel paradigm for precision treatment of inflammatory diseases.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Sun, J., Zhang, J., Lei, H., Tang, Q., Han, P., Xia, Y., Deng, R., Wang, Y., Shi, Y., Zhang, J., Zhang, Y., Han, Z., Huang, Y., Wu, Y., & Chen, L. (2026). An “anaerobic invisible” genetically engineered bacterium for periodontitis treatment through temporal modulation on microenvironment. Dental Research, 1(1), 100002. https://doi.org/10.1016/j.dtrs.2025.100002
Vancouver
Sun J, Zhang J, Lei H, Tang Q, Han P, Xia Y, et al. An “anaerobic invisible” genetically engineered bacterium for periodontitis treatment through temporal modulation on microenvironment. Dental Research. 2026;1(1):100002. doi:10.1016/j.dtrs.2025.100002
BibTeX
@article{Sun2026,
author = {Sun, Jiwei and Zhang, Junshuai and Lei, Haoqi and Tang, Qingming and Han, Pingping and Xia, Yutian and Deng, Ronghua and Wang, Yifan and Shi, Yunsong and Zhang, Junyuan and Zhang, Yifan and Han, Zhenshuo and Huang, Yingjia and Wu, Yuzhou and Chen, Lili},
title = {An “anaerobic invisible” genetically engineered bacterium for periodontitis treatment through temporal modulation on microenvironment},
journal = {Dental Research},
year = {2026},
volume = {1},
number = {1},
pages = {100002},
doi = {10.1016/j.dtrs.2025.100002}
}
EUVIMED